906 results about "Mannitol" patented technology

The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.

The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.

The invention relates to the field of agricultural microbial preparations, in particular to a complex microbial inoculant sustained-release granule for preventing and treating sweet potato stem nematode disease and a preparation method of the complex microbial inoculant sustained-release granule. Comprising the following components in parts by weight: 15-25 parts of paecilomyces lilacinus viable bacterium powder, 10-20 parts of bacillus thuringiensis viable bacterium powder, 10-20 parts of streptomyces viable bacterium powder, 5-15 parts of bacillus subtilis viable bacterium powder, 15-25 parts of charcoal, 5-15 parts of sodium alginate, 5-15 parts of humic acid, 5-10 parts of chitosan, 3-8 parts of calcium silicate, 1-5 parts of mannitol and 1-5 parts of sodium lignin sulfonate. Four microorganisms with complementary functions, namely paecilomyces lilacinus, bacillus thuringiensis, streptomycete and bacillus subtilis, are adopted, the sweet potato stem nematode disease is synergistically controlled through multiple action mechanisms, and the control effect and the stability are remarkably improved.

The invention provides a melogabalin besylate tablet and a preparation method thereof, the melogabalin besylate tablet comprises a plain tablet and a coating, the plain tablet comprises, by mass, 4.39% of melogabalin besylate, 75-85% of mannitol 150SD, 3-10% of a disintegrating agent, 0.5-3% of a lubricant, 0.1-0.5% of an adsorbent, 1-10% of a filler, 0.5-3% of an antioxidant A and 0.1-3% of an antioxidant B; and the coating comprises the following components in percentage by mass: 30-45% of talcum powder, 2-10% of lauryl sodium sulfate, 30-45% of glycerol monocaprylate / dicaprylate, 2-10% of titanium dioxide, 30-45% of polyvinyl alcohol, 0.5-2% of iron oxide yellow and 0.5-2% of iron oxide red. The melogabalin besylate tablet prepared by the invention uses specific coating composition and specific coating parameters, so that the melogabalin besylate tablet can be stably stored without a drying agent and a composite aluminum bag for medicine packaging, the stability of the tablet is greatly improved, the complexity of equipment required by production is simplified, and the production cost is greatly saved.

The invention relates to a functional microorganism-containing organic-inorganic compound fertilizer and a production method thereof, and relates to the technical field of fertilizers, the functional microorganism-containing organic-inorganic compound fertilizer comprises an inorganic core layer, an organic coating layer and a functional microorganism outer layer, the functional microorganism outer layer comprises the following components in parts by mass: 10-15 parts of compound functional microorganisms, 5-10 parts of synergistic growth-promoting microorganisms, 2-3 parts of trehalose, 1-2 parts of mannitol, 10-15 parts of sodium alginate, 8-10 parts of chitosan, 2-4 parts of a yeast extract and 30-40 parts of a modified activated carbon carrier. The production method comprises the following steps: preparing an inorganic core layer, preheating the inorganic core layer, and spraying and coating an organic coating layer material to obtain a primary product with an organic coating layer; and coating the surface of the organic coating layer of the primary product with a functional microorganism outer layer material, drying at low temperature, and screening to obtain the organic-inorganic compound fertilizer containing the functional microorganisms. The fertilizer has the effect of improving the slow release effect of the fertilizer and the survival rate of microorganisms.

Veterinary pharmaceutical compositions for direct systemic introduction, also known as DSI pharmaceutical compositions. One veterinary pharmaceutical composition for direct systemic introduction includes about 10-17 dry mass % bovine gelatin; about 10-17 dry mass % mannitol; about 0-1 dry mass % of a surfactant; and about 65-80 dry mass % of the active pharmaceutical ingredient which is a proton pump inhibitor. A method of manufacturing a veterinary pharmaceutical composition for direct systemic introduction includes combining one or more pharmacologically inactive compounds to form a first solution; using one or more surfactants to form a second solution; adding an active pharmaceutical ingredient to the second solution to form a first mixture; adding the first solution to the first mixture to form a pre-formulation; freezing the pre-formulation; and lyophilizing the pre-formulation.

The invention provides a preparation method of mannitol carbonic acid sulfate, mannitol and dimethyl carbonate are used as starting raw materials to prepare mannitol carbonic acid sulfate, a target compound is obtained through ester exchange, cyclization and oxidation reaction, the raw materials are low in price and easy to obtain, the reaction operation is simple and convenient, the yield of the obtained product is 81% or above, the purity is 99.6% or above, and the method is suitable for industrial production. The method is suitable for industrial production.

The invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts thereof, medical kits, and methods for using such ophthalmic solutions to improve visual performance in a patient. Exemplary aqueous ophthalmic solutions include those containing phentolamine mesylate, mannitol, sodium acetate, and water.

The invention discloses collagen polypeptide firming and anti-wrinkle freeze-dried powder, and relates to the technical field of cosmetics. The invention relates to a biological preservative which is prepared from water, butanediol, a bacillus / soybean fermentation product extract, soluble collagen, acetyl hexapeptide-8, panthenol, 1, 2, 4-trimethyl-1, 3-pentanediol and a proper amount of water. The cosmetic is prepared from 1, 2-hexanediol, tetrahydromethylpyrimidine carboxylic acid, hydroxypropyl tetrahydropyrantriol, tremella polysaccharide, saccharide isomeride, a bifidus yeast fermentation product lysate, sodium hyaluronate, DNA sodium, a radix gentianae extract, mannitol, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7, oligopeptide-1, decapeptide-4, oligopeptide-3, hydrolyzed royal jelly protein, folic acid and disodium hydrogen phosphate. The additive is composed of sodium dihydrogen phosphate, citric acid and sodium citrate. The mask can provide rich nutrients for skin, deeply care the skin, moisturize and relieve the skin, tighten the skin, resist wrinkles and make the skin moisturized, glossy, elastic and tight, and is high in use safety and wide in application prospect.

The present invention relates to the screening of functional probiotics and its application, and specifically provides a strain of Lactobacillus casei RH99 that produces high extracellular polysaccharides and relieves vaginitis, and its preservation number is CGMCC No.32108. The Lactobacillus casei can inhibit the growth of Gardnerella, Candida albicans, and Peptostreptococcus and their biofilm generation ability; the extracellular polysaccharides produced by it have a significant promoting effect on the biofilm formation of Lactobacillus casei itself. RH99 is inoculated into the vagina, and its strain, the metabolites (exocellular polysaccharides) produced, and the core monosaccharide (D-mannitol) can all inhibit the colonization of pathogenic bacteria and promote the colonization of lactic acid bacteria; and RH99 can also relieve vaginitis by inhibiting inflammatory factors. It can be seen that RH99 can inhibit the growth of pathogenic bacteria + inhibit biofilm formation + inhibit pathogenic bacteria adhesion + inhibit the level of inflammatory factors through key core metabolites, and realize the all-round inhibition of four-in-one.

The application relates to an organic-inorganic compound fertilizer containing functional microorganisms and a production method thereof, and relates to the technical field of fertilizers. The fertilizer comprises an inorganic core layer, an organic coating layer and a functional microorganism outer layer. The functional microorganism outer layer comprises the following components in mass fractions: 10-15 parts of compound functional microorganisms, 5-10 parts of synergistic growth-promoting microorganisms, 2-3 parts of trehalose, 1-2 parts of mannitol, 10-15 parts of sodium alginate, 8-10 parts of chitosan, 2-4 parts of yeast extract and 30-40 parts of modified active carbon carriers. The production method comprises the following steps: preparing the inorganic core layer, preheating the inorganic core layer, spraying the organic coating layer material to coat the surface, and obtaining a preliminary product with the organic coating layer; coating the functional microorganism outer layer material on the surface of the organic coating layer of the preliminary product, low-temperature drying and screening, and obtaining the organic-inorganic compound fertilizer containing the functional microorganisms. The application has the effects of improving the slow-release effect of the fertilizer and the survival rate of the microorganisms.

The invention belongs to the field of biology, and discloses a CRISPR / Cas12a freeze-dried microsphere, which is characterized in that the CRISPR / Cas12a freeze-dried microsphere is obtained by freeze-drying the following raw materials: enzyme-free water, 10 * HOLMES Buffer for Cas12a, an RNA enzyme inhibitor, CRISPR / Cas12a protein, crRNA, an upstream primer F, a downstream primer R, a fluorescent probe Reporter and a freeze-drying protective additive; the CRISPR / Cas12a protein is an LbaCas12a protein, and the CRISPR / Cas12a protein is a Cas12a protein; the freeze-drying protective agent is prepared from mannitol, trehalose, polyethylene glycol, glucan and BSA (Bovine Serum Albumin). By further optimizing a freeze-drying protective agent, freeze-drying microballing of a CRISPR / Cas12a system is achieved, the freeze-drying microballing can be matched with RPA constant-temperature amplification double microballing, and detection is conducted through a one-step method. Meanwhile, the invention further discloses a three-microsphere detection system, application and a kit.

The invention relates to the technical field of eutectic crystals, in particular to a lutein and mannitol eutectic crystal as well as a preparation method and application thereof, an XRD (X-Ray Diffraction) pattern of the eutectic crystal has characteristic diffraction peaks at least at positions where 2 theta angles are 9.71 degrees, 19.44 degrees, 20.4 degrees, 21.17 degrees, 22.07 degrees, 24.67 degrees, 25.32 degrees, 36.1 degrees, 40.39 degrees and 44.9 degrees, and error tolerance of + / -0.2 degrees exists; a characteristic endothermic peak exists at 163.7 DEG C in a DSC spectrum, and an error tolerance of + / -0.2 DEG C exists; the preparation method comprises the following steps: respectively dissolving mannitol and xanthophyll in water and absolute ethyl alcohol, mixing, carrying out high-temperature and high-pressure reaction, standing, crystallizing, filtering, spray-drying and grinding to obtain the eutectic crystal, and the eutectic crystal can be applied to cosmetics, health-care products, foods and medicines. The eutectic crystal provided by the invention has the advantage of good stability.

The invention belongs to the technical field of stem cell biological preparations, and particularly relates to an anti-aging compound preparation based on stem cells and application of the anti-aging compound preparation in delaying skin aging. The composition is composed of an inner water phase, a middle oil phase and an outer water phase, wherein the inner water phase is prepared from the following components: stem cell exosomes, hyaluronic acid, nicotinamide ribose, trehalose, mannitol, glycine and a citric acid buffer solution; the medium oil phase is prepared from the following components: medium chain triglyceride, shea butter, vitamin E succinate, PEG (Polyethylene Glycol) modified ceramide NP and cholesterol succinic acid monoester; the external water phase is prepared from the following components: polydatin, cellulose nanocrystals and an emulsifying agent. On the basis of a W / O / W emulsion system, a multi-layer anti-aging mechanism is constructed by utilizing a three-dimensional delivery framework of an inner water phase, an oil phase and an outer water phase and space-time synergy of active ingredients, the exosome permeation efficiency is improved through microneedle introduction, and the anti-oxidation and barrier repair effects are achieved by using multiple ingredients.

The invention provides a battery and an electric device. A positive plate comprises a positive active material, and the positive active material is doped and / or coated with a lanthanum element; the surface of the diaphragm is coated with a ceramic coating; the electrolyte comprises a first solvent, a second solvent, a first additive and a second additive; the first solvent comprises a cyclic carbonate compound, the second solvent comprises a chain fluorosulfonamide compound, the first additive comprises mannitol carbonate sulfate, and the second additive comprises succinonitrile; the lanthanum element is doped / coated on the positive active material, so that the release of lattice oxygen at high voltage or high temperature can be effectively inhibited, and the exothermic reaction activity at the thermal runaway initial temperature is reduced; the first additive and the second additive in the electrolyte respectively form a compact CEI film and an SEI film with high thermal stability on the surfaces of the positive electrode and the negative electrode; the diaphragm ceramic coating provides a physical barrier, the thermal shrinkage temperature of the diaphragm is increased, and internal short circuit is prevented.

The invention discloses a low-temperature vacuum microwave freeze-dried sinomenine hydrochloride preparation and a preparation method thereof in the technical field of pharmaceutical preparations, and solves the problems of long drying time, high energy consumption and poor product stability in the traditional freeze-drying technology. A vacuum microwave collaborative freeze-drying technology is adopted, microwave internal heating is achieved through a 2.45 GHz magnetron microwave generator and a rectangular waveguide tube under the conditions that the vacuum degree is 20-30 Pa and the plate layer temperature ranges from-40 DEG C to-35 DEG C, the microwave power density in the primary drying stage ranges from 0.3 W / g to 0.5 W / g, the microwave power density in the secondary drying stage ranges from 0.1 W / g to 0.3 W / g, and collaborative control over the microwave power, the vacuum degree, the temperature and the time is achieved in cooperation with a quaternary coupling precise control system. The preparation contains 50 mg of sinomenine hydrochloride, 100 mg of mannitol and 10 mg of sodium carboxymethyl cellulose grafted modified polyvinylpyrrolidone, the residual moisture is controlled to be 0.4-0.6%, the activity retention rate is 94-96%, and the drying time is shortened to 12-16 hours.

The invention discloses a recombinant III-type human collagen composition. The recombinant III-type human collagen composition comprises recombinant III-type human collagen, a first buffer solution and a stabilizer, the stabilizer is selected from at least one of glycerol, butanediol, pentanediol, mannitol and trehalose. According to the recombinant III type human collagen composition, a chemical cross-linking agent or an enzymatic promoter is not added for cross-linking, and the used reagents are free of cytotoxicity, sensitization and other safety risks. Therefore, the recombinant III-type human collagen composition has no crosslinking agent residue, can form a three-dimensional network structure, can avoid the problem that the recombinant III-type human collagen and the polysaccharide are compounded to generate precipitates, also has good biocompatibility, degradability and high stability, especially has relatively high thermal stability, and can be used for preparing the recombinant III-type human collagen composition. The wound healing and repairing can be promoted, the healthy skin ecology can be reconstructed, and a new choice is provided for a biomedical material.

The invention relates to the technical field of purification of fine chemical intermediates, in particular to a purification method of a mannitol carbonate sulfate preparation process intermediate, which comprises the following steps: S1, synthesizing diacetone-D-mannitol; s2, preparing an organic solution containing solids; s3, performing deprotection reaction to prepare a solid crude product; s4, removing unreacted solids; s5, extracting and separating by-product solids; and S6, purifying the target product solid and recovering mannitol. Through system separation and multi-component recovery, preparation of a high-purity product and cyclic utilization of unreacted substances, byproducts and raw materials are realized, the yield is remarkably improved, the cost is reduced, and the quality of a final product is guaranteed.

The present invention relates to a high-temperature starch-type wetting agent and a preparation method and application thereof, wherein the wetting agent comprises an active ingredient and water, wherein the mass ratio of the active ingredient to the water is (0.05-0.15): 1, and the active ingredient comprises the following raw materials in parts by weight: 45-65 parts of a starch-based film-forming agent, 5-10 parts of a plasticizer, 15-20 parts of a lubricant, 1-2.5 parts of an emulsifier, 4-6 parts of a coupling agent, 0.5-1.5 parts of a preservative, and 0.02-0.05 parts of a defoaming agent; wherein the plasticizer is cardanol acetate, tributyl citrate, and mannitol in a mass ratio of 1:1:(1.5-2); and the starch-based film-forming agent is at least one of acetylated distarch adipate, oxidized starch, and hydroxypropyl starch. The glass fiber yarn products produced with the wetting agent have significantly reduced scattered silk defects on the cloth surface, and the amount of powder falling during the weaving process is also greatly reduced, which meets the high standard requirements for the production of printed circuit boards.

The invention relates to the technical field of crop cultivation, and particularly discloses a method for increasing the anthocyanin content of triticale grains, which comprises the following steps: respectively spraying 80-100 times of leaf fertilizer diluent once at the elongation stage and filling stage of triticale growth, and spraying 6-10kg / mu each time; the formula of the foliar fertilizer is as follows: 100 mg to 150 mg of mannose, 100 mg to 150 mg of fructose, 130 mg to 160 mg of mannitol, 160 mg to 200 mg of betaine, 180 mg to 200 mg of alginic acid, 180 mg to 200 mg of fucoidin, 300 mg to 350 mg of amino acid and 1000 g of water. According to the method, the content of anthocyanin in triticale grains can be remarkably increased by spraying 80-100 times of foliar fertilizer diluent prepared by the method in the elongation stage and the pustulation stage of the triticale.

The invention provides an anti-freezing denaturation agent for golden and tiger hybrid spotted fish meat protein and a preparation method of the anti-freezing denaturation agent. The invention relates to an anti-freezing denaturation agent for protein of Jinhu hybrid spotted fish. The anti-freezing denaturation agent is prepared from the following raw materials in parts by weight: 5 to 8 parts of trehalose-mannitol, 0.5 to 1 part of nano chitosan, 0.2 to 0.5 part of rosmarinic acid and 0.1 to 0.2 part of polysorbate-80. The trehalose-mannitol is prepared from trehalose and mannitol. Aiming at the characteristics of Jinhu hybrid spotted fish meat, trehalose-mannitol, nano chitosan, rosmarinic acid and polysorbate-80 are taken as raw materials and compounded to obtain a new formula of the protein anti-freezing denaturation agent for the Jinhu hybrid spotted fish meat, and the anti-freezing denaturation agent prepared by adopting the formula and the process disclosed by the invention can be used for inhibiting protein degradation and improving the anti-freezing denaturation effect of the Jinhu hybrid spotted fish meat. The decrease range of MP protein concentration, MP total sulfydryl content and MP Ca < 2 + >-ATPase activity of the antifreeze agent is obviously reduced, and the effect of the antifreeze agent is superior to that of a commercially available antifreeze agent. Moreover, the anti-freezing denaturation agent for the protein of the Jinhu hybrid spotted fish does not contain phosphorus, and has the advantages of safety and high efficiency.

The present invention discloses a tofacitinib citrate sustained-release tablet preparation and a preparation method thereof, which belongs to the technical field of pharmaceutical preparations. The sustained-release tablet comprises a double-layer core and a coating layer; the double-layer core comprises a drug-containing layer and a push layer; wherein the drug-containing layer comprises: tofacitinib citrate, an adhesive, polyethylene oxide, a glidant and a lubricant; the push layer comprises: mannitol, an adhesive, red iron oxide, polyethylene oxide, a glidant and a lubricant; the coating layer comprises: cellulose acetate, a pore-forming agent, a plasticizer, water and acetone. The sustained-release tablet preparation of the present invention solves the technical problems existing in the prior art by adopting a double-layer osmotic pump prescription design, adopting non-hygroscopic materials such as mannitol, adopting a standard round tablet design, preparing a sustained-release coating layer without using methanol, and adopting a coating machine for coating and curing.

The invention discloses a cryoprotectant which comprises glycerol, skimmed milk powder, mannitol, trehalose, vitamin C, fructo-oligosaccharide, inulin and sterile water. By optimizing the components of the cryoprotectant, the activity of the coprophilous fungi can be effectively protected, the survival rate of the intestinal coprophilous fungi in the freezing process is remarkably increased, all the used components are food-grade edible components and have a wide application range and economic effects, the invention further discloses a coprophilous fungi freezing preservation method adopting the cryoprotectant, and the cryoprotectant has good application prospects. The method is simple, easy to operate and suitable for large-scale production and application.

The invention belongs to the technical field of chemical detection, and particularly relates to a method for detecting the content of boron in soil and sediment, which comprises the following detection methods: S1, weighing a sample and putting the sample into a digestion tank; s2, adding a digestion solution into the digestion tank; s3, after uniform stirring, putting the digestion tank into a microwave digestion instrument for microwave digestion; s4, after digestion is completed, closing the microwave digestion instrument, and after the digestion tank is cooled to the room temperature, filtering to remove precipitates; s5, transferring the digestion solution into a volumetric flask, and fixing the volume for subsequent analysis; and S6, analyzing the digestion solution by using ICP-OES / MS (Inductively Coupled Plasma-Optical Emission According to the method for detecting the boron content in the soil and the sediment, ammonium fluoride is used for replacing hydrofluoric acid in boron detection of the soil and the sediment, use of toxic reagents is reduced, mannitol is added, a stable complex is formed by mannitol and boron, and the recovery rate of boron is increased.

The invention discloses a low-temperature storage and preservation method for litchis. The method comprises the following steps of: removing branches and leaves of fresh litchis which are 80-90% mature, and reserving bare litchis; the fruits pass through a sorting line, and defective fruits are picked out; and soaking the lychee in an ergothioneine and mannitol solution, draining water, packaging the lychee with a moisture-permeable and air-permeable functional fresh-keeping bag, and storing the lychee at the temperature of-1 DEG C to 5 DEG C. According to the fresh-keeping method combining ergothioneine, mannitol and a moisture-permeable and air-permeable functional fresh-keeping bag, the fresh-keeping period of the litchis can be effectively prolonged through natural oxidation resistance and hydration and by matching with humidity adjustment and gas exchange, and the flavor, texture and nutritional ingredients of the litchis are kept. The method not only meets green and environment-friendly requirements, but also can remarkably reduce loss of litchis in transportation and storage, reduce food waste and improve food safety, and is an advanced and efficient fruit fresh-keeping technology.

The invention relates to the technical field of pharmaceutical preparations, and provides an oral solid preparation for treating gout and a preparation method thereof. The preparation method comprises the following steps: sieving a filling agent, a disintegrating agent, an adhesive and dotenorad to obtain a sieved material; and mixing the sieved material and a lubricant, and tabletting to obtain the oral solid preparation for treating gout, the filling agent is lactose, mannitol and microcrystalline cellulose. By optimizing the prescription and the preparation process, the dissolution rate and bioavailability of the medicine are improved, so that the curative effect is improved; by selecting proper auxiliary materials and preparation types, the stimulation to gastrointestinal tracts is reduced, and the tolerance of patients is improved; the oral solid preparation is convenient to take, accurate in dosage, high in patient compliance and beneficial to long-term treatment; moreover, the preparation method provided by the invention is simple to operate, easy for industrial production and relatively low in cost.

The invention discloses stem cell freeze-dried powder for promoting skin healing and a preparation method of the stem cell freeze-dried powder. The freeze-dried powder comprises an effective component, a freeze-drying protective agent group and a polymer protective agent group, the effective component is umbilical cord mesenchymal stem cell conditioned medium freeze-dried supernatant, the protective agent group is selected from one or more of cane sugar, trehalose, lactose and mannitol, and the polymer protective agent group is selected from one or more of polyvinylpyrrolidone (PVP) and glucan. The preparation method comprises the following steps: collection of a conditioned culture medium, preparation of a freeze-drying protective agent solution, mixing treatment, low-temperature pre-freezing and freeze-drying, collection and packaging of freeze-dried powder and the like. The method can effectively retain stem cell-derived active factors and enhance the stability and redissolvability of the freeze-dried powder, and is suitable for skin wound repair, regenerative medicine and other scenes.

The invention provides collagen modified superoxide dismutase and a preparation method and application thereof, the preparation method comprises the following steps: dissolving collagen in water, sequentially adding superoxide dismutase, EDC and NHC into the water, and stirring in a water bath heat preservation state to obtain a flowable gel sample; diluting the obtained gel sample with water, centrifuging, and collecting a lower-layer viscous liquid; and adding the centrifuged viscous liquid into a PBS (phosphate buffer solution), and dialyzing to obtain the collagen modified superoxide dismutase. Trehalose and mannitol are added into the collagen modified superoxide dismutase, the mixture is stirred and mixed evenly, the mixture is poured into a mold to be freeze-dried and extruded to be flat, and the repairing patch is obtained. The crosslinking modified superoxide dismutase obtained in the invention has good stability, and the obtained repair patch is convenient to use, can promote wound healing, and has wide application prospects and practical significance.

This application relates to a deoxyribonucleic acid and pseudovirus preservation solution, its preparation method and application. The deoxyribonucleic acid and pseudovirus preservation solution includes: a buffer solution with a final concentration of 5 mM to 50 mM, a surfactant with a volume percentage of 0.05% to 1.0%, trehalose with a final concentration of 50 mM to 500 mM, a metal ion chelator with a final concentration of 0.5 mM to 5 mM, betaine with a final concentration of 100 mM to 1000 mM, and mannitol with a mass percentage of 1% to 10%. Each specific component in the above-mentioned deoxyribonucleic acid and pseudovirus preservation solution cooperates with each other at a specific concentration, which has the effect of stabilizing the state and structure of nucleic acids. It can achieve the preservation of nucleic acids and pseudoviruses without ultra-low temperature, and can stably preserve nucleic acids and pseudoviruses for up to 12 months at 30°C without affecting subsequent detection tests.

The invention belongs to the technical field of medical detection, and particularly relates to a freeze-drying protective agent, an antibody freeze-dried microsphere stock solution, an antibody freeze-dried microsphere and application thereof. The freeze-drying protective agent comprises trehalose, mannitol, polyethylene glycol 8000, a protein protective agent, a surfactant, a preservative and a PBS (Phosphate Buffer Solution). The antibody freeze-dried microsphere based on the freeze-drying protective agent has excellent stability, and still has stable performance after being stored for 90 days at room temperature; however, the currently obtained lymphocyte subpopulation detection reagents need to be stored at 4 DEG C; in addition, the consistency of the detection result of the lymphocyte subpopulation detection reagent and the currently obtained lymphocyte subpopulation detection reagent is high.